Form 4: Twist Bioscience Executive Sells Shares to Cover Tax Obligations

A Twist Bioscience executive sold shares to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• Robert F. Werner, Chief Accounting Officer of Twist Bioscience Corp, sold 226 shares of common stock on December 6, 2024.
• The sale was executed at a price of $52.704 per share, totaling $11,911.20.
• The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
• These sales are mandated by the company's equity incentive plans and do not represent discretionary trades by the executive.

Sentiment

Score: 5

Explanation: The document describes a routine transaction related to executive compensation and does not indicate any positive or negative sentiment.

Industry Context

This type of transaction is common for executives who receive stock-based compensation, as they often need to sell shares to cover the associated tax liabilities.

Comparison to Industry Standards

• Many biotechnology companies use restricted stock units as part of their compensation packages.
• It is standard practice for companies to have 'sell to cover' mechanisms in place to handle tax obligations related to vesting stock.

Stakeholder Impact

• The sale of shares by the executive has a minimal impact on shareholders as it is a routine transaction.

Key Dates

Keywords

Twist Bioscience, TWST, stock sale, executive, tax withholding, restricted stock units, equity incentive plans